Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Mesa Laboratories Q4 2024 GAAP EPS $(47.20) May Not Be Comparable To $(0.12) Estimate, Sales $58.904M Beat $55.275M Estimate

Author: Benzinga Newsdesk | June 05, 2024 06:15am

Posted In: MLAB